Article Details

ONTOZRY® (Cenobamate) Receives European Commission Approval for the Treatment of Drug ...

Retrieved on: 2021-03-30 22:52:30

Tags for this article:

Click the tags to see associated articles and topics

ONTOZRY® (Cenobamate) Receives European Commission Approval for the Treatment of Drug .... View article details on hiswai: https://www.prnewswire.com/news-releases/ontozry-cenobamate-receives-european-commission-approval-for-the-treatment-of-drug-resistant-focal-onset-seizures-in-adults-301259077.html

Excerpt

SK Biopharmaceuticals, which discovered and developed cenobamate, will collaborate with Angelini Pharma to launch ONTOZRY® in Europe.

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up